A citation-based method for searching scientific literature

Adriano Chiò, Letizia Mazzini, Gabriele Mora. Neuropharmacology 2020
Times Cited: 24







List of co-cited articles
219 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Decoding ALS: from genes to mechanism.
J Paul Taylor, Robert H Brown, Don W Cleveland. Nature 2016
903
29

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.
Leonard H van den Berg, Eric Sorenson, Gary Gronseth, Eric A Macklin, Jinsy Andrews, Robert H Baloh, Michael Benatar, James D Berry, Adriano Chio, Philippe Corcia,[...]. Neurology 2019
62
25

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Rita Mejzini, Loren L Flynn, Ianthe L Pitout, Sue Fletcher, Steve D Wilton, P Anthony Akkari. Front Neurosci 2019
147
25


The clinical trial landscape in amyotrophic lateral sclerosis-Past, present, and future.
Heike J Wobst, Korrie L Mack, Dean G Brown, Nicholas J Brandon, James Shorter. Med Res Rev 2020
17
29

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
Henk-Jan Westeneng, Thomas P A Debray, Anne E Visser, Ruben P A van Eijk, James P K Rooney, Andrea Calvo, Sarah Martin, Christopher J McDermott, Alexander G Thompson, Susana Pinto,[...]. Lancet Neurol 2018
157
20

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.
D R Rosen, T Siddique, D Patterson, D A Figlewicz, P Sapp, A Hentati, D Donaldson, J Goto, J P O'Regan, H X Deng. Nature 1993
20

Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial.
Jesus S Mora, Angela Genge, Adriano Chio, Conrado J Estol, Delia Chaverri, Maria Hernández, Saúl Marín, Javier Mascias, Gabriel E Rodriguez, Monica Povedano,[...]. Amyotroph Lateral Scler Frontotemporal Degener 2020
54
20

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Robert G Miller, J D Mitchell, Dan H Moore. Cochrane Database Syst Rev 2012
402
20

Amyotrophic Lateral Sclerosis.
Robert H Brown, Ammar Al-Chalabi. N Engl J Med 2017
592
20

Amyotrophic lateral sclerosis.
Orla Hardiman, Ammar Al-Chalabi, Adriano Chio, Emma M Corr, Giancarlo Logroscino, Wim Robberecht, Pamela J Shaw, Zachary Simmons, Leonard H van den Berg. Nat Rev Dis Primers 2017
393
16

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.
Timothy M Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H Appel, Patricia L Andres, Katy Mahoney, Peggy Allred, Katie Alexander,[...]. Lancet Neurol 2013
390
16

Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials.
Syed I Khalid, Leonel Ampie, Ryan Kelly, Shafeeq S Ladha, Christopher Dardis. Front Neurol 2017
22
18

Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets.
Giovanna Morello, Antonio Gianmaria Spampinato, Sebastiano Cavallaro. Mediators Inflamm 2017
23
17

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Henk-Jan Westeneng, Stavros Nikolakopoulos, Iris E Verhagen, Michael A van Es, Marinus J C Eijkemans, Leonard H van den Berg. Neurology 2019
36
16


Trial of celecoxib in amyotrophic lateral sclerosis.
Merit E Cudkowicz, Jeremy M Shefner, David A Schoenfeld, Hui Zhang, Katrin I Andreasson, Jeffrey D Rothstein, Daniel B Drachman. Ann Neurol 2006
200
16

State of play in amyotrophic lateral sclerosis genetics.
Alan E Renton, Adriano Chiò, Bryan J Traynor. Nat Neurosci 2014
890
16

ALS drug development guidances and trial guidelines: Consensus and opportunities for alignment.
Jinsy A Andrews, Lucie I Bruijn, Jeremy M Shefner. Neurology 2019
8
50


Inflammation in ALS/FTD pathogenesis.
Madelyn E McCauley, Robert H Baloh. Acta Neuropathol 2019
78
16

TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
Ching-Chieh Chou, Yi Zhang, Mfon E Umoh, Spencer W Vaughan, Ileana Lorenzini, Feilin Liu, Melissa Sayegh, Paul G Donlin-Asp, Yu Han Chen, Duc M Duong,[...]. Nat Neurosci 2018
206
12

ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
Dmitry Petrov, Colin Mansfield, Alain Moussy, Olivier Hermine. Front Aging Neurosci 2017
180
12

Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.
Kevin D Foust, Desirée L Salazar, Shibi Likhite, Laura Ferraiuolo, Dara Ditsworth, Hristelina Ilieva, Kathrin Meyer, Leah Schmelzer, Lyndsey Braun, Don W Cleveland,[...]. Mol Ther 2013
124
12

Clinical trials in amyotrophic lateral sclerosis.
Christopher J McDermott. Curr Opin Neurol 2019
10
30

Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
Hiroshi Mitsumoto, Benjamin R Brooks, Vincenzo Silani. Lancet Neurol 2014
167
12

Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis.
Savina Apolloni, Paola Fabbrizio, Susanna Amadio, Giulia Napoli, Veronica Verdile, Giovanna Morello, Rosario Iemmolo, Eleonora Aronica, Sebastiano Cavallaro, Cinzia Volonté. Front Immunol 2017
22
13

Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis.
Silas Maniatis, Tarmo Äijö, Sanja Vickovic, Catherine Braine, Kristy Kang, Annelie Mollbrink, Delphine Fagegaltier, Žaneta Andrusivová, Sami Saarenpää, Gonzalo Saiz-Castro,[...]. Science 2019
108
12

Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex.
Eleonora Aronica, Frank Baas, Anand Iyer, Anneloor L M A ten Asbroek, Giovanna Morello, Sebastiano Cavallaro. Neurobiol Dis 2015
42
12

Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS.
Angelo C Lepore, Christine Haenggeli, Mehdi Gasmi, Kathie M Bishop, Raymond T Bartus, Nicholas J Maragakis, Jeffrey D Rothstein. Brain Res 2007
89
12

Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis.
Natalia Nowicka, Jakub Juranek, Judyta K Juranek, Joanna Wojtkiewicz. Int J Mol Sci 2019
27
12

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.
Brian K Kaspar, Jerònia Lladó, Nushin Sherkat, Jeffrey D Rothstein, Fred H Gage. Science 2003
653
12

A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS.
Udaya Geetha Vijayakumar, Vanessa Milla, Mei Yu Cynthia Stafford, Anthony J Bjourson, William Duddy, Stephanie Marie-Rose Duguez. Front Neurol 2019
24
12

A revision of the El Escorial criteria - 2015.
Albert Ludolph, Vivian Drory, Orla Hardiman, Imaharu Nakano, John Ravits, Wim Robberecht, Jeremy Shefner. Amyotroph Lateral Scler Frontotemporal Degener 2015
230
12

Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.
Johannes Brettschneider, Kelly Del Tredici, Jon B Toledo, John L Robinson, David J Irwin, Murray Grossman, EunRan Suh, Vivianna M Van Deerlin, Elisabeth M Wood, Young Baek,[...]. Ann Neurol 2013
524
12

The multistep hypothesis of ALS revisited: The role of genetic mutations.
Adriano Chiò, Letizia Mazzini, Sandra D'Alfonso, Lucia Corrado, Antonio Canosa, Cristina Moglia, Umberto Manera, Enrica Bersano, Maura Brunetti, Marco Barberis,[...]. Neurology 2018
67
12


The phenotypic variability of amyotrophic lateral sclerosis.
Bart Swinnen, Wim Robberecht. Nat Rev Neurol 2014
288
12

Amyotrophic lateral sclerosis.
Matthew C Kiernan, Steve Vucic, Benjamin C Cheah, Martin R Turner, Andrew Eisen, Orla Hardiman, James R Burrell, Margaret C Zoing. Lancet 2011
12

Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study.
Ryuji Kaji, Takashi Imai, Yasuo Iwasaki, Koichi Okamoto, Masanori Nakagawa, Yasuo Ohashi, Takao Takase, Takahisa Hanada, Hiroki Shimizu, Kunio Tashiro,[...]. J Neurol Neurosurg Psychiatry 2019
22
13

Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.
Emiliano Trias, Sofía Ibarburu, Romina Barreto-Núñez, Joël Babdor, Thiago T Maciel, Matthias Guillo, Laurent Gros, Patrice Dubreuil, Pablo Díaz-Amarilla, Patricia Cassina,[...]. J Neuroinflammation 2016
74
12

Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, Bas M Middelkoop, Toby A Ferguson, Pamela J Shaw, P Nigel Leigh, Ammar Al-Chalabi, Marinus J C Eijkemans, Leonard H van den Berg. J Neurol Neurosurg Psychiatry 2019
6
50

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS.
Namita A Goyal, James D Berry, Anthony Windebank, Nathan P Staff, Nicholas J Maragakis, Leonard H van den Berg, Angela Genge, Robert Miller, Robert H Baloh, Ralph Kern,[...]. Muscle Nerve 2020
12
25


Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.
Sami J Barmada, Andrea Serio, Arpana Arjun, Bilada Bilican, Aaron Daub, D Michael Ando, Andrey Tsvetkov, Michael Pleiss, Xingli Li, Daniel Peisach,[...]. Nat Chem Biol 2014
268
12

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.
Mariely DeJesus-Hernandez, Ian R Mackenzie, Bradley F Boeve, Adam L Boxer, Matt Baker, Nicola J Rutherford, Alexandra M Nicholson, NiCole A Finch, Heather Flynn, Jennifer Adamson,[...]. Neuron 2011
12

Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
T Kawamata, H Akiyama, T Yamada, P L McGeer. Am J Pathol 1992
430
12

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.
Alan E Renton, Elisa Majounie, Adrian Waite, Javier Simón-Sánchez, Sara Rollinson, J Raphael Gibbs, Jennifer C Schymick, Hannu Laaksovirta, John C van Swieten, Liisa Myllykangas,[...]. Neuron 2011
12

Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial.
Esther Verstraete, Jan H Veldink, Mark H B Huisman, Tim Draak, Esther V Uijtendaal, Anneke J van der Kooi, H Jurgen Schelhaas, Marianne de Visser, Ingeborg van der Tweel, Leonard H van den Berg. J Neurol Neurosurg Psychiatry 2012
50
12

Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Ashley R Jones, William Sproviero, Aleksey Shatunov, Pamela J Shaw, P Nigel Leigh, Carolyn A Young, Christopher E Shaw, Gabriele Mora, Jessica Mandrioli,[...]. Neurology 2017
34
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.